FGF2 and neoplasm: Given that hSef-b negatively regulates cellular responses to the angiogenesis promoting factor FGF2, and to NF-κB whose targets are involved in angiogenesis [e.g. VEGF, and MMP-936], we hypothesized that hSef-b expression might affect tumor growth also by inhibiting the process of tumor angiogenesis.